Voloridge Investment Management
SGYP

Voloridge Investment Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Voloridge Investment Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-138,145
Closed -$841K – 773
2016
Q4 		$841K Buy
+138,145
New +$722K 0.02% 508
2015
Q3 		– Sell
-53,501
Closed -$444K – 437
2015
Q2 		$444K Buy
+53,501
New +$259K 0.02% 260

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Voloridge Investment Management's SGYP Position: Q1 2017 in Review

Voloridge Investment Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2017, closing a stake of 138,145 shares — an estimated $841K sold.

Voloridge Investment Management first reported a position in SGYP in Q2 2015 and held it in 2 quarters. The position peaked at $841K in Q4 2016. 164 funds tracked by Wall St. Rank hold SGYP as of Q1 2017.

  • Voloridge Investment Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2017 after selling out during the quarter.
  • Voloridge Investment Management sold 138,145 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2017, an estimated $841K.
  • Voloridge Investment Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 2 quarters.
  • Voloridge Investment Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $841K in Q4 2016.
  • 164 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2017.

Based on Voloridge Investment Management's 13F filing for Q1 2017, filed 15 May 2017.